The European Medicines Agency (EMA) will start an ongoing evaluation of the coronary pill Molnupiravir next week. A Danish chief physician thinks the pill looks promising.
–
The pill can prevent the coronavirus from multiplying, and in that way there are fewer viruses in the body, explains professor at Aarhus University and chief physician at Aarhus University Hospital, Lars Østergaard.
– This means that the risk of infection transmission is reduced, and that you can thus help to slow the spread of infection, he says.
According to the manufacturer Merck, the corona pill can halve the risk of hospitalization and death.
The US authorities have previously said that they will invest more than NOK 25 billion in the development of antiviral drugs against covid-19 and other dangerous viruses.
–
–
